Novo Holdings A/S’s Pharvaris PHVS Stock Holding History

Novo Holdings A/S’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.4M	Hold	1,750,000	–	–	4.01%	10
2025 Q4	$48.6M	Hold	1,750,000	–	–	3.77%	10
2025 Q3	$43.7M	Buy	1,750,000 +25,000	+1%	+$555K	2.81%	12
2025 Q2	$30.4M	Hold	1,725,000	–	–	2.14%	16
2025 Q1	$27.1M	Hold	1,725,000	–	–	2.06%	16
2024 Q4	$33.1M	Hold	1,725,000	–	–	2%	15
2024 Q3	$31.9M	Hold	1,725,000	–	–	1.59%	20
2024 Q2	$32.4M	Buy	1,725,000 +556,970	+48%	+$11.3M	1.75%	17
2024 Q1	$27M	Sell	1,168,030 -371,295	-24%	-$9.86M	1.86%	20
2023 Q4	$43.2M	Buy	1,539,325 +210,000	+16%	+$4.25M	2.67%	13
2023 Q3	$27.7M	Hold	1,329,325	–	–	2.05%	19
2023 Q2	$20.1M	Hold	1,329,325	–	–	1.56%	23
2023 Q1	$10.7M	Buy	1,329,325 +142,018	+12%	+$1.25M	0.71%	37
2022 Q4	$13.4M	Buy	1,187,307 +577,307	+95%	+$3.04M	0.83%	35
2022 Q3	$4.68M	Buy	610,000 +90,661	+17%	+$1.42M	0.22%	47
2022 Q2	$11.5M	Buy	519,339 +3,018	+0.6%	+$56.2K	0.57%	33
2022 Q1	$9.37M	Hold	516,321	–	–	0.49%	36
2021 Q4	$7.43M	Buy	516,321 +97,378	+23%	+$1.52M	0.35%	39
2021 Q3	$7.43M	Buy	418,943 +307,799	+277%	+$5.27M	0.38%	37
2021 Q2	$2.07M	Buy	111,144 +61,144	+122%	+$1.39M	0.09%	52
2021 Q1	$1.4M	Buy	+50,000	New	+$1.57M	0.06%	49

Other funds holding PHVS

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $1.02B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Novo Holdings A/S's PHVS Position: Q1 2026 in Review

Novo Holdings A/S held its Pharvaris (PHVS) position steady in Q1 2026 at 1,750,000 shares worth $49.4M. The position accounts for 4.01% of the portfolio, ranked #10.

Novo Holdings A/S first reported a position in PHVS in Q1 2021 and has held it in 21 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

Novo Holdings A/S held 1,750,000 shares of Pharvaris worth $49.4M as of Q1 2026.
Novo Holdings A/S left its Pharvaris share count unchanged in Q1 2026.
Pharvaris made up 4.01% of Novo Holdings A/S's portfolio in Q1 2026, its #10 holding.
Novo Holdings A/S first reported a position in Pharvaris in Q1 2021 and has held it in 21 quarters since.
110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Novo Holdings A/S's 13F filing for Q1 2026, filed 15 May 2026.